Introduction
============

The prevention of bone fractures is an important goal in a society with increasing longevity. It is recognized that patients with type 2 diabetes mellitus are increasing worldwide, and a meta-analysis has shown that diabetic patients have a higher hip fracture risk than people without diabetes[@b1]--[@b3]. Hip fractures are related to chronic pain and disability, loss of independence, decreased quality of life, and increased mortality.

Although osteoporosis is often thought to be a disease of women, studies show that osteoporotic fractures also result in substantial morbidity, mortality and costs in men[@b4]--[@b6]. It has been reported that mortality during the first 3 months after hip fracture is higher in men than in women, and more than one-third of men who developed a hip fracture died within 1 year[@b7],[@b8].

However, as the increased fracture risk in men is not sufficiently well known, bone density examinations are infrequent in outpatient clinics. Limited data are available on the relationship between lifestyle and bone status in male patients with type 2 diabetes mellitus[@b1],[@b6]. Evidence for the benefit of preventive interventions, such as health education on diabetic patients\' quality of life, on relieving the burden on caregivers and on decreasing the costs of fractures, is lacking.

Methods
=======

Data Selection
--------------

Heel bone stiffness was measured in 154 male patients with type 2 diabetes mellitus aged 30--83 years who visited the outpatient clinic of the Ryukyu University Hospital. Patients with type 1 diabetes, impaired glucose tolerance (IGT) and slowly progressive insulin-dependent diabetes mellitus (SPIDDM) were excluded. Patients with conditions that could affect bone metabolism, such as osteomalacia, compression fracture, rheumatoid arthritis, thyroidectomy, gastrectomy, duodenectomy, kidney disease, nephrectomy and adrenalectomy, as well as those on medications that affect bone metabolism, were also excluded from the analysis.

The background characteristics of the type 2 diabetes mellitus patients, including blood pressure, retinopathy and nephropathy, were assessed. Nephropathy was classified according to the kidney disease improving global outcomes 2012 criteria[@b9]. Patients with nephropathy grades 3b, 4 and 5 who have an estimated glomerular filtration rate (e-GFR) of \<44 mL/min/1.73 m^2^ were also excluded from the analysis. Thus, 108 male patients with type 2 diabetes mellitus were ultimately selected for the present study.

Heel bone stiffness was also examined in 185 age-adjusted healthy volunteers who underwent the local resident medical health check-up; 168 male participants aged 30--83 years satisfied the selection criteria (Figure[1](#fig01){ref-type="fig"}).

![Case-finding protocol. IGT, impaired glucose tolerance; SPPDM, slowly progressive insulin-dependent diabetes mellitus.](jdi0006-0150-f1){#fig01}

Coding Procedures
-----------------

The face-to-face baseline interviews were carried out using a semistructured questionnaire.

The associations between lifestyle factors and heel bone stiffness were examined. The lifestyle factors were daily dietary calcium intake, habitual exercise, sunlight exposure, cigarette smoking and consumption of alcohol. Dietary calcium intake was estimated by a semiquantitative food frequency questionnaire. Daily dietary intake of a glass of milk or small fish was divided into five frequencies: one to two times a day, once a day, once in 2--3 days, once a week and none at all. Sunlight exposure was divided into three categories: mostly indoors, outdoors for shopping or commuting and mostly working outdoors. Habitual exercise was assessed by regular exercise currently and regular exercise at 20 years-of-age. Cigarette smoking was divided into two categories: currently smoking, smoked in the past or never smoked. Consumption of alcohol was divided into three categories: drink daily, drink sometimes and never drank (Table[1](#tbl1){ref-type="table"}).

###### 

Screening factors and the 15 factors analyzed

  Questionnaire
  -------------------------------------------------------------------------------------------------------------------------
  I. Check for diseases related to bone status[\*](#tf1-1){ref-type="table-fn"}
   Thyroid or parathyroid gland diseases, gastrectomy, kidney disease, RA, osteoporosis and prescribed calcium supplement
  II\. Age and physique status
   1. Age
   2. Height
   3. Weight
   4. BMI
  III\. Lifestyle-related factors
  *Daily calcium intake from diet*
   5. Glass of milk intake
   1--2 times a day, once a day, once in 2--3 days, once a week, none at all
   6. Small fish intake: smelts (semi-dried) or sardines (niboshi)
   1--2 times a day, once a day, once in 2--3 days, once a week, none at all
  *Usual lifestyle and exercise*
   7. Regular exercise currently
   8. Regular exercise at 20 years-of-age
   9. Sunlight exposure
  Mostly indoors, outdoors for or shopping or commuting, mostly working outdoors
  *Preferences*
   10. Cigarette smoking: smoking currently, smoked in the past or never smoked
   11. Consumption of alcohol: drink daily, drink sometimes, never drank
  *Remaining no. teeth*
   12. No. remaining teeth
  Patients\' medical history
  IV\. Diabetes status
   13. Presumed diabetes duration
   14. Glycated hemoglobin
   15. Treatment
   16. Blood pressure
   17. Retinopathy
   18. Nephropathy

BMI, body mass index; RA, rheumatoid arthritis. These were excluded from the analysis.

Participants\' characteristics, which included age, height, weight and body mass index (BMI), were investigated from their medical records. Diabetic status, such as diabetes duration, levels of glycated hemoglobin \[HbA~1c~; National Glycohemoglobin Standardization Program (NGSP)\], treatment, blood pressure, retinopathy and nephropathy, were also studied in the type 2 diabetes mellitus group[@b10].

Bone Parameters
---------------

Heel bone stiffness was measured using quantitative ultrasound (QUS; AchillesA-1000 PLUS; Lunar Corp., Madison, WI, USA). QUS is recommended for infants and pregnant women, because it does not involve X-rays. Its low cost and portability could make QUS an especially valuable osteoporosis detection tool wherever cost or instrument inaccessibility renders dual-energy X-ray absorptiometry (DXA) difficult or impossible[@b11]. The theoretical foundation of QUS is based on the variation in the speed of the ultrasound wave (SOS), in units of m/s, and its attenuation along its transmission path, at frequencies of 0.4--1.0 MHz. Ultrasound waves pass faster in bone with higher density. In addition, as ultrasound passes through bone, it undergoes attenuation, with a consequent loss of transmitted acoustic energy. The slope of attenuation as a function of frequency \[the broadband ultrasound attenuation (BUA), in units of dB/MHz\] is lower in more porous and less microstructurally intact bone. Aside from SOS and BUA, the most common derived variable is 'bone stiffness,' a linear combination of SOS and BUA[@b12]. The investigation was carried out from 1999 to 2000.

Statistical Analysis
--------------------

In the descriptive analysis of baseline characteristics, the data are expressed as means ± SD. The Pearson product-moment correlation coefficient and regression analysis were used to compare aging and bone stiffness in both groups. Levine\'s test, Student\'s *t*-test and the chi square-test were used to compare both groups. One-way analysis of variance ([anova]{.smallcaps}) was carried out to compare classification factors and bone stiffness in the type 2 diabetes group. Stepwise regression analysis was carried out to compare lifestyle factors and bone stiffness. All statistical analyses were carried out using SPSS version 17 (SPSS, Chicago, IL, USA).

Ethical Considerations
----------------------

Informed consent was obtained from all participants. It was explained that no additional fee would be charged for the heel QUS**,** and that being enrolled in the investigation would not affect their medical care. After the heel QUS was measured, the participants were immediately given an explanation of the measured value, with appropriate health advice.

Results
=======

Participants\' Characteristics
------------------------------

Overall, 108 male patients with type 2 diabetes mellitus and 168 male healthy controls were selected for the present study. The average age was 59.7 ± 10.0 years (range 30--80 years) in type 2 diabetes mellitus patients and 60.5 ± 11.7 years (range 30--83 years) in controls. The average height was 162.1 ± 5.5 cm (range 152--178 cm) in type 2 diabetes mellitus patients and 160.6 ± 6.2 cm (range 147--177 cm) in controls. Weight was 65.3 ± 8.8 kg (range 46--88 kg) and 63.8 ± 9.0 kg (range 45--94 kg), and BMI was 24.8 ± 2.8 kg/m^2^ (range 19--33 kg/m^2^) and 24.7 ± 2.8 kg/m^2^ (range 18--34 kg/m^2^), respectively. These parameters, except for height, were almost identical in the two groups.

The mean duration of illness of type 2 diabetes mellitus patients was 12.7 ± 8.2 years (range 0.8--32 years), and the mean glycated hemoglobin (HbA~1c~; NGSP) was 8.0 ± 1.8% (5.6--13.8%)[@b10]. They were treated with diet (*n* = 32), insulin injections (*n* = 23) or oral hypoglycemic agents (*n* = 53), with patients taking several antidiabetic agents, such as sulfonylureas (*n* = 44), α-glycosidase inhibitors (*n* = 14), biguanides (*n* = 12) or others (*n* = 1).

The average bone stiffness was 87.8 ± 14.8% in type 2 diabetes mellitus patients and 87.9 ± 14.7% in controls. In normal weight (BMI \<25 kg/m^2^) participants, the average bone stiffness was 83.7 ± 16.3% in type 2 diabetes mellitus patients and 88.6 ± 14.9% in controls, whereas in overweight (BMI ≥25 kg/m^2^) participants, it was 90.2 ± 13.8% in type 2 diabetes mellitus patients and 87.2 ± 14.4% in controls. Fractures occurred in 10 (9.3%) type 2 diabetes mellitus patients and 12 (7.1%) controls (Table[2](#tbl2){ref-type="table"}).

###### 

Characteristics of type 2 diabetes mellitus patients and controls

                                                   Type 2 diabetes mellitus patients (*n* = 108)   Controls (*n* = 168)     *P*-value
  ------------------------------------------------ ----------------------------------------------- ------------------------ ----------------------------------------
  Age, years (range)                               59.7 ± 10.0 (30--80)                            60.5 ± 11.7 (30--83)     0.553
  Height, cm (range)                               162.1 ± 5.5 (152--178)                          160.6 ± 6.2 (147--177)   0.044[\*](#tf2-2){ref-type="table-fn"}
  Weight, kg (range)                               65.3 ± 8.8 (46--88)                             63.8 ± 9.0 (45--94)      0.161
  BMI, kg/m^2^ (range)                             24.8 ± 2.8 (19--33)                             24.7 ± 2.8 (18--34)      0.704
  Duration of diabetes, years (range)              12.7 ± 8.2 (0.8--32)                                                     
  HbA~1c~ (%) (NGSP)                               8.0 ± 1.8 (5.6--13.8)                                                    
  Therapeutic modality                             Diet (*n* = 32)                                                          
  Insulin (*n* = 23)                                                                                                        
  OHA[†](#tf2-3){ref-type="table-fn"} (*n* = 53)                                                                            
  Sulfonylurea (*n* = 44)                                                                                                   
  α-Glucosidase inhibitor (*n* = 14)                                                                                        
  Biguanide (*n* = 12)                                                                                                      
  Others (*n* = 1)                                                                                                          
  Bone stiffness (%)                               87.8 ± 14.8                                     87.9 ± 14.7              0.673
  Normal weight (BMI \<25 kg/m^2^)                 83.7 ± 16.3 (*n* = 51)                          88.6 ± 14.9 (*n* = 88)   0.078
  Overweight (BMI ≥25 kg/m^2^)                     90.2 ± 13.8 (*n* = 57)                          87.2 ± 14.4 (*n* = 80)   0.227
  History of fracture                              10 (9.3%)                                       12 (7.1%)                0.401
  Smoking currently                                26 (24.1%)                                      42 (25.0%)               0.157
  Smoked in the past or never smoked               82 (75.9%)                                      124 (73.8%)              0.157
  Unknown                                          --                                              2 (1.2%)                 

BMI, body mass index; HbA~1c~, glycated hemoglobin; NGSP, National Glycohemoglobin Standardization Program. Results are expressed as means ± SD (range). Analysis using Levene\'s test, Student\'s *t*-test or the chi square-test.

*P* \< 0.05.

Oral hypoglycemic agents (OHA), some patients took more than one drug. No patients took pioglitazone.

Table[3](#tbl3){ref-type="table"} shows the background characteristics of the type 2 diabetes mellitus patients. Blood pressure was classified according to the standard 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement[@b13]. Diabetic retinopathy was graded as no diabetic retinopathy (NDR), simple diabetic retinopathy, preproliferative diabetic retinopathy (pre-PDR) and proliferative diabetic retinopathy (PDR) according to the diagnostic classification by Davis *et al*.[@b14] Nephropathy was classified based on cause, GFR stage and albuminuria stage according to the Kidney Disease: Improving Global Outcomes 2012 criteria[@b9].

###### 

Background characteristics of type 2 diabetes mellitus patients

  Characteristic                                                           Classification                                       *n* (%) *n* = 108   Stiffness (%) mean ± SD   *P*-value[\*](#tf3-1){ref-type="table-fn"}
  ------------------------------------------------------------------------ ---------------------------------------------------- ------------------- ------------------------- --------------------------------------------
  Blood pressure                                                           Normal pressure (120--139 mmHg/80--89 mmHg)          54 (50.0)           87.2 ± 15.4               0.323
  Hypertension (≥140 mmHg/90 mmHg or under treatment)                      51 (47.2)                                            88.1 ± 15.1                                   
  Hypotension (\<120 mmHg/80 mmHg)                                         3 (2.8)                                              69.7 ± 7.2                                    
  Retinopathy                                                              No diabetic retinopathy                              56 (51.9)           87.6 ± 14.8               0.453
  Simple diabetic retinopathy                                              28 (25.9)                                            85.3 ± 16.8                                   
  Preproliferative diabetic retinopathy                                    7 (6.5)                                              89.3 ± 10.8                                   
  Proliferative diabetic retinopathy                                       10 (9.3)                                             85.0 ± 18.4                                   
  Unknown                                                                  7 (6.5)                                              91.6 ± 14.6                                   
  Nephropathy                                                              Grade 1 (normal or high: GFR ≥90 mL/min/1.73 m^2^)   61 (56.5)           87.4 ± 15.4               0.379
  Grade 2 (mildly decreased: GFR 60--89 mL/min/1.73 m^2^)                  36 (33.3)                                            85.1 ± 16.0                                   
  Grade 3a (mildly or moderately decreased: GFR 45--59 mL/min/1.73 m^2^)   11 (10.2)                                            93.0 ± 11.9                                   

GFR, glomerular filtration rate; SD, statdard deviation. Results are means ± SD. No patients were undergoing dialysis or receiving vitamin D treatment. ^\*^*P* \< 0.05, analysis using analysis of variance, with no significant differences.

Age-Related Bone Loss
---------------------

Heel bone stiffness decreased with age in both groups, but it was significantly associated with age only in controls. The regression slope was flatter in type 2 diabetes mellitus than in controls. Furthermore, from the 30 s to the 40 s, heel bone stiffness was lower in type 2 diabetes mellitus patients than in controls (type 2 diabetes mellitus, stiffness = −0.19 × age + 98.5, *r* = 0.12, *P* = 0.20; controls, stiffness = −0.33 × age + 107.9, *r* = 0.26, *P* = 0.01; Figure[2](#fig02){ref-type="fig"}).

![Relationship between age and heel bone stiffness on quantitative ultrasound.](jdi0006-0150-f2){#fig02}

Lifestyle Factor Effects
------------------------

Table[4](#tbl4){ref-type="table"} shows that 108 type 2 diabetes mellitus patients and 168 control subjects were included in categorical comparisons that included age, height, weight, BMI, intake of a glass of milk or small fish intake as part of the daily diet, regular exercise currently or at 20 years-of-age, sunlight exposure, cigarette smoking, consumption of alcohol and the number of remaining teeth.

###### 

Stepwise regression analysis of bone stiffness in type 2 diabetes mellitus patients and controls

                       Dependent variable                                                       
  -------------------- -------------------- ------- -------- ------- --------- ------- -------- -------
  Age (years)          --0.207                      7.565    0.033   --0.371           12.076   0.000
  Height (cm)                                                        --0.193           7.898    0.018
  Sunlight exposure                                                  0.182             9.589    0.013
  Small fish intake                                                  0.170             7.393    0.023
  Cigarette smoking    --0.297                      10.059   0.003                              
  *n*                                       108                                168              
  Significance (*P*)                        0.001                              0.000            
  Adjusted *R*^2^                           0.139                              0.155            
  *F*-value                                 7.565                              7.393            

Controls: eight factors poorly fitting factors (weight, body mass index, milk intake, regular exercise at 20 years-of-age, regular exercise currently, cigarette smoking, consumption of alcohol and number of remaining teeth). Type 2 diabetes mellitus patients: 13 poorly fitting factors (height, weight, body mass index, milk intake, small fish intake, regular exercise at 20 years-of-age, regular exercise currently, sunlight exposure, consumption of alcohol, number of remaining teeth, diabetes duration, glycated hemoglobin and treatments for diabetes).

Weight and BMI had no significant correlations with heel bone stiffness in both groups. However, age had significant negative associations with bone stiffness in both groups \[type 2 diabetes mellitus, standardized coefficient (SC) = −0.207, *F*-value (*F*) = 7.565; controls, SC = −0.371, *F* = 12.076\]. Furthermore, cigarette smoking was significantly negatively associated with heel bone stiffness in type 2 diabetes mellitus only (SC = −0.297, *F* = 10.059). In contrast, sunlight exposure and small fish intake were significantly associated with heel bone stiffness in controls only (sunlight exposure, SC = 0.182, *F* = 9.589; small fish intake, SC = 0.170, *F* = 7.393).

Duration of diabetes, HbA~1c~ and treatment were not associated with heel bone stiffness.

Discussion
==========

Osteoporosis is defined as a skeletal disorder characterized by compromised bone strength predisposing to an increased fracture risk. Bone strength reflects the integration of two main features: bone density and bone quality. Bone density is expressed as grams of mineral per area or volume, and in any given individual it is determined by peak bone mass and amount of bone loss. Bone quality refers to architecture, turnover, damage accumulation and mineralization. A fracture occurs when a failure-inducing force is applied to osteoporotic bone[@b15].

QUS methods have been introduced in recent years for the assessment of skeletal status in osteoporosis. Current evidence supports the use of QUS techniques for the assessment of fracture risk in elderly women. This has been best established for water-based calcaneal QUS systems. The rules of physics describe the relationships among mechanical preperties, 3-D bone architecture and velocity or attenuation of transmitted ultrasonic waves. QUS parameters could allow one to assess the mechanical properties of cortical and trabecular bone, which in turn are important determinants of whole bone stiffness and fracture risk[@b16].

A meta-analysis has suggested that low QUS values are associated with overall fracture risk, low-trauma fractures, and with hip and other fractures in older women; the association is similar to that seen with DXA[@b17]. BUA is associated with an increased risk for hip fracture. Intertrochanteric fractures in particular are strongly associated with a low BUA measurement[@b18]. These indices indirectly describe bone micro-architectural features, such as trabecular spacing, orientation and connectivity, as well as bone density[@b10]. Additionally, the heel bone is weight-bearing and contains approximately 90% trabecular bone, which has a high metabolic turnover rate and a pattern of bone loss similar to the spine. Bone stiffness might be thought to be almost the same as 'bone strength', which is a combined indicator of 'bone density' and 'bone quality.'

Previous studies reported that diabetic patients had higher bone mineral density (BMD; g/cm^2^) than those without diabetes, despite an increased fracture risk[@b1]--[@b3]. This phenomenon might be explained by poor bone quality rather than BMD. Recent studies have suggested that collagen cross-linking, a low level of serum vitamin B~6~, and advanced glycation end-products play an important role in bone quality[@b19],[@b20]. Based on the present definition, both BMD and bone quality, which encompass the structural and material properties of bone, are important factors in the determination of 'bone strength'[@b15].

In the present study, aging was shown to reduce heel bone stiffness in both groups. The regression slope was flatter in type 2 diabetes mellitus patients than in controls, and from the 30 s to the 40 s, heel bone stiffness was lower in type 2 diabetes mellitus patients than in controls.

These estimates in men were remarkably similar to those in women with type 2 diabetes mellitus[@b21]. The metabolic effects of poor glycemic control could lead to bone loss in the initial stage of type 2 diabetes mellitus. Based on a previous study, in patients with diabetes, a low bone formation rate retards bone accumulation during growth, and low bone turnover retards age-related bone loss. In the elderly with a long duration of type 2 diabetes mellitus, the low bone turnover delays bone loss, and might eventually result in bone density that exceeds the value expected for age[@b22].

The present data suggest that cigarette smoking is a significant risk factor for decreased bone strength in type 2 diabetes mellitus. A meta-analysis showed that cigarette smoking produced the greatest increases in hip fracture risk (40%) in men[@b23]. There is growing evidence that cigarette smoking is a risk factor for the development of type 2 diabetes[@b24],[@b25]. Cigarette smoking is associated with insulin resistance, and affects calcium and vitamin D metabolism[@b26],[@b27]. Furthermore, smokers with diabetes have an increased rate of microvascular complications, cardiovascular disease (CVD) and premature death. Therefore, the American Diabetes Association recommends that all patients not smoke[@b24].

Okinawans have approximately 20% fewer hip fractures than mainland Japanese[@b28]. It has been found that diabetic osteopenia was higher in northern Japan, Hokkaido and Tohoku regions, than in southern Japan, Kyushu and Chugoku-Shikoku regions[@b29]. Total mean monthly sunlight exposure in 2000 was 32,235 MJ/m[@b2] in Okinawa and 27,818 MJ/m^2^ in northern areas (Sapporo)[@b30]. Okinawa is the southernmost point in Japan, and the amount of sunlight exposure per unit is higher than that received in northern areas; therefore, spending time outside allows Okinawan men to have optimal vitamin D levels year round.

Calcium is an essential nutrient for critical biological functions, such as nerve conduction, muscle contraction and structural support of the skeleton. Studies show that, among Japanese women, plants and fish contributed 46.7% of total dietary calcium, whereas 32.4% was derived from milk[@b31]. Japanese people are accustomed to traditional dishes, such as fish, especially small fish eaten with soft and edible bones, like sardines and smelts. One hundred grams of milk, smelts (semi-dried) and sardines (niboshi) contain 110, 380, and 2200 mg of calcium per 100 g edible portion, respectively[@b32]. Smelts are not a common food in Okinawa, but sardines (niboshi) are very commonly eaten. Regarding the data concerning calcium intake in men, the total mean intake was 516 mg/day in Japan and 444 mg/day in Okinawa. As for dried small fish intake in men, total mean intake was 16 g/day in Japan and 5 g/day in Okinawa[@b33],[@b34]. Therefore, the calcium intake was lower in Okinawan men than in mainland Japanese men.

The positive relationships between small fish intake and sunlight exposure and bone stiffness, which were seen in controls, disappeared in patients with type 2 diabetes mellitus. Patients with diabetes require more calcium intake and sunlight exposure than those without diabetes, because of increased calcium loss from urine with glycosuria or exacerbating diabetic complications, such as kidney failure.

Bone loss appears to be progressive in diabetic patients with chronic kidney disease (CKD). A previous study has noted that patients with initial eGFR 43.8 ± 3.6 mL/min/1.73 m^2^ were not on dialysis after 2-year follow up[@b35]. Another study has reported that parathyroid hormone (PTH) was found to be elevated in more than 20% of CKD grade 3 patients[@b36]. PTH stimulates the bone metabolism and rotation. PTH increases the phosphate excretion in urine by acting on a proximal renal tubule, PTH also increases reabsorption of calcium with stimulating production of activated vitamin D (1α, 25\[OH\]~2~ D~3~). Therefore, complicating factors are involved in calcium homeostasis and bone metabolism in type 2 diabetes patients with renal failure. Consequently, patients with nephropathy grades 3b, 4 and 5 with an eGFR of \<44 mL/min/1.73 m^2^ were excluded from the analysis in the present study.

It has also been reported that diabetic retinopathy is associated with fracture risk[@b37]. The effects of atherosclerosis, or increased advanced glycation end-products, which are often seen in diabetic patients with retinopathy and/or nephropathy, might be involved. The metabolic effects of diabetes on the skeleton are complex. Further study is required to determine whether intervention could prevent the reduction of bone strength and hip fractures in diabetic patients.

Although there are several life factors, cigarette smoking was strongly associated with bone strength in patients with diabetes mellitus; therefore, all patients with diabetes should not smoke.
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